Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1918139

Cover Image

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1918139

Breast Implants Market - Forecast from 2026 to 2031

PUBLISHED:
PAGES: 149 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3950
PDF (Multiple User License)
USD 4550
PDF (Enterprise License)
USD 6950

Add to Cart

The breast implants market, with a 7.53% CAGR, is projected to rise from USD 2.912 billion in 2025 to USD 4.501 billion in 2031.

The breast implants market is experiencing robust growth at a 7.53% CAGR, projected to reach USD 4.501 billion in 2031. These medical devices-used to enhance breast size and shape through surgical procedures-serve both cosmetic and reconstructive purposes. Rising breast cancer prevalence, increasing beauty consciousness, awareness about breast reconstruction, technological advancements in implant systems, and rising disposable income are propelling market expansion.

Primary Market Drivers

Breast Cancer Prevalence and Reconstruction

Breast implants are commonly used in breast reconstruction procedures following mastectomy due to breast cancer. Rising breast cancer cases are expected to propel market growth substantially. Breast cancer represents the most prevalent cancer type globally. Approximately 2.3 million new breast cancer instances occurred in 2020, with approximately 685,000 deaths worldwide. The IARC estimates that by 2040, there will be more than 3 million new breast cancer instances annually-a 40% increase-and more than 1 million annual fatalities-a 50% increase. This growing disease burden creates sustained demand for reconstructive procedures utilizing breast implants.

Beauty Consciousness and Cosmetic Demand

Recent years have witnessed growing trends of people seeking cosmetic enhancements to improve physical appearance. Increasing emphasis on beauty and body image in society has driven the breast implants market. According to the 2023 annual Global Survey on Aesthetic/Cosmetic Procedures conducted by the International Society of Aesthetic Plastic Surgery, plastic surgeons worldwide reported a significant 19.3% increase in overall procedures performed in 2021. The survey revealed that more than 12.8 million surgical procedures and approximately 17.5 million non-surgical procedures were conducted globally during that year. Breast augmentation was the most common surgical procedure for women, demonstrating the procedure's mainstream acceptance and popularity.

Technological Innovation

Technological innovations in breast implant materials and design have improved safety, durability, and natural appearance. Advancements in implant surfaces, such as textured implants, have helped reduce the risk of implant rotation and capsular contracture. Modern breast implants often use cohesive silicone gel, which maintains shape and integrity even if the implant shell is compromised. Nanotechnology has influenced breast implant development by creating nanostructured surfaces that enhance tissue integration and reduce complications like capsular contracture. Advanced 3D imaging and simulation technologies allow patients to visualize potential outcomes before undergoing surgery, supporting improved decision-making and patient satisfaction.

Economic Accessibility

Economic prosperity and increasing disposable income in various regions have allowed more individuals to afford cosmetic procedures, making breast implants more accessible to broader demographics. Rising disposable income is expected to bolster market growth. India's gross disposable income witnessed 6.4% growth in fiscal year 2019-20, reaching Rs. 204.22 lakh crore. China's per capita disposable income was 35,128 yuan (approximately $5,523) in 2021, an increase of 9.1% year over year in nominal terms. These economic improvements expand the addressable market for both cosmetic and reconstructive breast procedures.

Market Constraints

Despite positive growth trajectories, the breast implants market faces challenges. The cost of implants, surgeon's fees, anesthesia, and post-operative care may accumulate to significant expenses. Affordability might be a limiting factor for some people, potentially negatively impacting market expansion. Issues such as implant rupture, capsular contracture, implant-associated anaplastic large cell lymphoma (BIA-ALCL), and potential long-term health effects have raised questions about breast implant safety profiles. These concerns have led to increased scrutiny by health authorities and regulatory bodies, potentially affecting consumer confidence and market demand. Manufacturers must continuously address these safety concerns through improved designs and transparent communication.

Regional Dynamics

North America is expected to hold significant market share during the forecast period, supported by rising breast cancer cases, increasing disposable income, strong healthcare systems, and earlier adoption of technological advancements. Breast cancer is the second highest diagnosed cancer in the U.S., contributing to around 30% of all new female cancers each year. Breast augmentation ranks among the top 5 surgical procedures in America, demonstrating the procedure's established position in the region's aesthetic medicine landscape.

Market Players and Recent Developments

Major market players include Polytech Health & Aesthetics GmbH, offering Polytech Patient Pathway(TM) and B-Lite(R) lightweight implants; Motiva Implants, known for Ergonomix range of ergonomic gel-filled breast implants designed to adapt to patient movements; and Groupe Sebbin SAS, providing breast implant solutions including Sensity, Volupty, Purity, and Integrity.

The breast implants market continues evolving, driven by technological sophistication, growing procedural acceptance, and the dual demand from reconstructive needs following breast cancer treatment and elective cosmetic enhancement procedures. The convergence of improved safety profiles, enhanced aesthetic outcomes, and expanding economic accessibility positions the market for sustained growth as manufacturers innovate to address clinical challenges while meeting diverse patient preferences.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Breast Implants Market Segmentation

  • By Product
  • Silicone Breast Implants
  • Saline Breast Implants
  • By Shape
  • Round
  • Anatomical
  • By Application
  • Reconstructive Surgery
  • Cosmetic Surgery
  • By Geography
  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others
Product Code: KSI061615921

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. BREAST IMPLANTS MARKET BY PRODUCT

  • 5.1. Introduction
  • 5.2. Silicone Breast Implants
  • 5.3. Saline Breast Implants

6. BREAST IMPLANTS MARKET BY SHAPE

  • 6.1. Introduction
  • 6.2. Round
  • 6.3. Anatomical

7. BREAST IMPLANTS MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Reconstructive Surgery
  • 7.3. Cosmetic Surgery

8. BREAST IMPLANTS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. ALLERGAN (ABBVIE INC.)
  • 10.2. GC Aesthetics
  • 10.3. GROUPE SEBBIN SAS
  • 10.4. J&J MedTech
  • 10.5. Sientra Inc.
  • 10.6. Polytech Health & Aesthetics GmbH
  • 10.7. Motiva Implants
  • 10.8. Guangzhou Wanhe Plastic Materials Co., Ltd.
  • 10.9. LABORATOIRES ARION

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!